- About Us
- Nano-Social Network
- Nano Consulting
- My Account
Professor Wolfgang Heckl has been newly appointed as a supervisory board member of MagForce Nanotechnologies AG (Entry Standard segment of the Frankfurt Stock Exchange, ticker MF6), following the election of Dr. Peter Heinrich, until now deputy chairman of the supervisory board, as the new chief executive officer of MagForce effective January 1, 2010.
Professor Heckl is considered one of the world's leading experts in the field of nanotechnology. His commitment to ongoing research in nanotechnology from its very early stages and to building public awareness of this groundbreaking technology were recognized in 2004, when he received the European Union's Descartes Prize for Science Communication. Dr. Heckl was named professor of experimental physics at the Ludwig Maximilian University (LMU) in Munich in 1993, and has been general director of Germany's largest science museum, Munich's renowned Deutsches Museum, since 2004. Since 2009 he has additionally held the Oskar von Miller Professorship in Scientific Communication at the Technical University of Munich (TU München). He is involved in various scientific associations, including the Excellence Network NanoBioTechnology, as well as centers of scientific excellence such as the Center for NanoScience and the GeoBioCenter at the LMU in Munich.
"We are extremely pleased that Professor Heckl, who already in the past has served as a supervisory board member of MagForce Nanotechnologies AG, has declared his readiness to once again provide his active support and scientific expertise to MagForce," said Professor Walter Rust, chairman of the company's supervisory board. "Particularly in the further scientific development of its nanotechnology-based cancer therapy, MagForce will benefit from his close involvement."
This release may contain forward-looking statements and information which may be identified by formulations using terms such as "expects," "aims," "anticipates," "intends," "plans," "believes," "seeks," "estimates" or "will." Such forward-looking statements are based on our current expectations and certain assumptions which may be subject to a variety of risks and uncertainties. The results actually achieved by MagForce Nanotechnologies AG may substantially differ from these forward-looking statements.
About MagForce Nanotechnologies AG
MagForce Nanotechnologies AG is one of the world’s leading companies in the area of nanotechnology-based cancer treatment. Its patented Nano-Cancer® therapy allows the targeted destruction of tumors using superparamagnetic nanoparticles to generate heat. The nanotechnology from MagForce represents a revolutionary approach to the future successful treatment of solid tumors.
For more information, please click here
Public Relations Manager
Phone +49 30 308 380 31
Fax +49 30 308 380 99
Copyright © MagForce Nanotechnologies AGIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information